Read our cell line development brochure.
In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data Glasgow, UK – July 7, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launched of a new Released N-Glycan Assay for the in-depth profiling of IgG glycosylation. This new physico-chemical assay, More
To help Indian researchers access a portfolio of excellent services from BioOutsource and Cellca Glasgow, UK – June 29, 2016: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, is pleased to announce that its subsidiary BioOutsource has appointed Ravin Mehta as Technical Sales Specialist to enable customers to have access to More
Cellca’s Cell Line and Upstream Process Development Services Now Integrated Glasgow, UK – June 14, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced that its subsidiary BioOutsource launched an updated website to spotlight Sartorius Stedim Cellca’s cell line and upstream process development services for the biopharmaceutical industry. The new More
Click below to download.
Read our catalogue for safety testing of CHO Cell Banks
To Continue Building Analytical Capabilities for Testing Drugs and Vaccines Glasgow, UK – April 27, 2016: Sartorius Stedim BioOutsource, a leading provider of contract testing services to the biopharmaceutical industry, is pleased to announce that it is looking to almost double the scientific workforce at its Glasgow facilities in 2016. The new staff will help More
How Providing Comprehensive Data Can Accelerate Drug Development Glasgow, UK – April 21, 2016: Sartorius Stedim BioOutsource today announced that its scientific experts will be presenting a live webinar about optimizing biosimilar analysis on Thursday, June 2, at 3 pm BST, 10 am EDT. The webinar is essential listening for researchers who want to understand More
Sartorius Stedim BioOutsource Introduces Assays for Testing Biosimilarity of Three Leading Biologics
New ready-to-use assays enable quick and simple generation of precise biosimilar comparability data Glasgow, UK – March 22, 2016: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, presents a range of ready-to-use assays for testing Actemra, Stelara and Lucentis biosimilars. The new assays, launched by SSB’s subsidiary Sartorius Stedim BioOutsource, will More
Our Chief Scientific Officer, Daniel Galbraith recently spoke to Biocompare about ‘Smarter Bioprocess Design for Smoother Upscale’. To read the full article, click here.